Garcia-Del Rio D, Derhourhi M, Bonnefond A, Leblanc S, Guilloy N, Roucou X
Cell Death Dis. 2024; 15(9):712.
PMID: 39349928
PMC: 11442847.
DOI: 10.1038/s41419-024-07046-1.
Mann M, Singh V, Kumar L
Genes Dis. 2023; 10(4):1445-1456.
PMID: 37397551
PMC: 10311104.
DOI: 10.1016/j.gendis.2022.09.014.
cerne K, Kelhar N, Resnik N, Herzog M, Vodnik L, Veranic P
Pharmaceuticals (Basel). 2023; 16(6).
PMID: 37375854
PMC: 10304395.
DOI: 10.3390/ph16060907.
Morse D, Michalowski A, Ceribelli M, De Jonghe J, Vias M, Riley D
Cell Syst. 2023; 14(6):464-481.e7.
PMID: 37348462
PMC: 10424188.
DOI: 10.1016/j.cels.2023.05.003.
Martino J, Siri S, Calzetta N, Paviolo N, Garro C, Pansa M
Elife. 2023; 12.
PMID: 37073955
PMC: 10185344.
DOI: 10.7554/eLife.80254.
The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer.
Patel M, Wang Y, Bartom E, Dhir R, Nephew K, Matei D
Cancer Res. 2021; 81(15):3985-4000.
PMID: 34224372
PMC: 8338879.
DOI: 10.1158/0008-5472.CAN-21-0953.
Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.
Dominici C, Sgarioto N, Yu Z, Sesma-Sanz L, Masson J, Richard S
Clin Epigenetics. 2021; 13(1):54.
PMID: 33691794
PMC: 7948358.
DOI: 10.1186/s13148-021-01037-1.
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.
Natoli M, Bonito N, Robinson J, Ghaem-Maghami S, Mao Y
Cancer Immunol Immunother. 2020; 69(8):1391-1401.
PMID: 32200422
PMC: 7347689.
DOI: 10.1007/s00262-020-02544-5.
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Mukherjee A, Chiang C, Daifotis H, Nieman K, Fahrmann J, Lastra R
Cancer Res. 2020; 80(8):1748-1761.
PMID: 32054768
PMC: 10656748.
DOI: 10.1158/0008-5472.CAN-19-1999.
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells.
Salvati A, Gigantino V, Nassa G, Giurato G, Alexandrova E, Rizzo F
Cancers (Basel). 2019; 11(11).
PMID: 31689915
PMC: 6895927.
DOI: 10.3390/cancers11111720.
Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis.
Che L, Yang X, Ge C, El-Amouri S, Wang Q, Pan D
PLoS One. 2019; 14(5):e0216553.
PMID: 31091257
PMC: 6519829.
DOI: 10.1371/journal.pone.0216553.
Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas.
Hallas-Potts A, Dawson J, Herrington C
Sci Rep. 2019; 9(1):5515.
PMID: 30940866
PMC: 6445084.
DOI: 10.1038/s41598-019-41941-4.
The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples.
Penner-Goeke S, Lichtensztejn Z, Neufeld M, Ali J, Altman A, Nachtigal M
PLoS Genet. 2017; 13(4):e1006707.
PMID: 28376088
PMC: 5395197.
DOI: 10.1371/journal.pgen.1006707.
Role of copper transporters in platinum resistance.
Kilari D, Guancial E, Kim E
World J Clin Oncol. 2016; 7(1):106-13.
PMID: 26862494
PMC: 4734932.
DOI: 10.5306/wjco.v7.i1.106.
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression.
Shields B, Pecot C, Gao H, McMillan E, Potts M, Nagel C
Mol Syst Biol. 2015; 11(12):842.
PMID: 26655797
PMC: 4704493.
DOI: 10.15252/msb.20156308.
Recapitulation and Modulation of the Cellular Architecture of a User-Chosen Cell of Interest Using Cell-Derived, Biomimetic Patterning.
Slater J, Culver J, Long B, Hu C, Hu J, Birk T
ACS Nano. 2015; 9(6):6128-38.
PMID: 25988713
PMC: 5292984.
DOI: 10.1021/acsnano.5b01366.
Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.
Ren X, Wu X, Hillier S, Fegan K, Critchley H, Mason J
J Steroid Biochem Mol Biol. 2015; 150:54-63.
PMID: 25817828
PMC: 4429663.
DOI: 10.1016/j.jsbmb.2015.03.010.
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes.
Beaufort C, Helmijr J, Piskorz A, Hoogstraat M, Ruigrok-Ritstier K, Besselink N
PLoS One. 2014; 9(9):e103988.
PMID: 25230021
PMC: 4167545.
DOI: 10.1371/journal.pone.0103988.
Overexpression of piRNA pathway genes in epithelial ovarian cancer.
Lim S, Ricciardelli C, Oehler M, Tan I, Russell D, Grutzner F
PLoS One. 2014; 9(6):e99687.
PMID: 24932571
PMC: 4059699.
DOI: 10.1371/journal.pone.0099687.
ATP11B mediates platinum resistance in ovarian cancer.
Moreno-Smith M, Halder J, Meltzer P, Gonda T, Mangala L, Rupaimoole R
J Clin Invest. 2013; 123(5):2119-30.
PMID: 23585472
PMC: 3635722.
DOI: 10.1172/JCI65425.